MedlyPeds App: The mobile phone-based telemonitoring system (MedlyPeds) will enable cardiac patients to monitor their weight, blood pressure, and heart rate, using wireless home medical devices. In addition, they will answer questions about their symptoms and wellness using their mobile phone. The device measurements will be automatically and wirelessly transmitted to the mobile phone and then to a data server. Automated and individualized self-care messages, developed with the assistance of healthcare providers, will subsequently be sent to the patient based on the readings and reported symptoms.
Study summary
SickKids and UHN have developed MedlyPeds which is a smart phone application designed to remotely monitor patients with heart disease. This is a feasibility study which will enroll up to 30 patients with different types of heart disease to see which patient types may benefit the most from MedlyPeds if it were to be used for clinical monitoring. The study is gathering feedback about the app from patients, parents and clinicians to confirm how it needs to be modified to better serve the purpose in a future trial.
Eligibility
Sex
ALL
Min age
8 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria:
1. Consent provided.
2. Aged 8-18 years of age.
3. Ability to comply with using Medly (ex. able to stand on the weight scale, able to answer symptom questions, etc.)
4. Followed at the Hospital for Sick Children Cardiology Clinic for any of the following reasons:
1. Heart failure of any etiology
2. Congenital heart disease
3. Acquired heart disease (eg. Kawasaki disease, rheumatic heart disease, connective tissue disorders etc)
4. Pulmonary hypertension
5. Post-cardiac surgery including heart transplant and ventricular assist devices
Exclusion Criteria:
1. Unable to read or write in English.
2. Participating in another clinical trial that may confound the results.\* \*Participant may be re-screened for eligibility at a later date.
Primary outcome measure(s)
Percentage of MedlyPeds App Daily Check-In Completion — 3 months The primary outcome for this study is overall app engagement measured by completion of symptom check-ins and entry of clinical information (i.e physiologic parameters) by the subject into the app. The feasibility and acceptability of MedlyPeds will be assessed from feedback from patients, parents and clinicians through the end of study questionnaire and interviews.
Feasibility and acceptability of Medly Peds — 3 months The feasibility and acceptability of MedlyPeds will be assessed from feedback from patients, parents and clinicians through the scoring of usefullness and relevance on the end of study questionnaire.
Trial sites (1)
Facility
City
Region
Status
The Hospital for Sick Children
Toronto
Ontario
Recruiting
More The Hospital for Sick Children trials in Canada
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.